Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 Sep 16.
Published in final edited form as: Org Lett. 2005 Dec 8;7(25):5733–5735. doi: 10.1021/ol0525009

Formal Syntheses of (±)-Pinnaic Acid and (±)-Halichlorine

Rodrigo B Andrade 1, Stephen F Martin 1,*
PMCID: PMC2536714  NIHMSID: NIHMS64045  PMID: 16321034

Abstract

graphic file with name nihms64045u1.jpg

Concise formal syntheses of marine alkaloids (±)-pinnaic acid (1) and (±)-halichlorine (2) have been accomplished from a common intermediate. The syntheses illustrate the utility of selective olefin cross metathesis methodologies for the elaboration of advanced synthetic intermediates in complex molecule synthesis.


In 1996 Uemura and co-workers reported the isolation and structural characterization of two novel alkaloids. Pinnaic acid (1),1 which was isolated from the Okinawan bivalve Pinna muricata, was found to be a specific inhibitor of cytosolic phospholipase A2 (cPLA2) with an in vitro IC50 of 0.2 mM. cPLA2 is involved in regulating inflammation and thus represents a potential target for drug discovery. Halichlorine (2), which was isolated from the marine sponge Halichondria okadai Kadota (Figure 1),2 inhibits the expression of vascular cell adhesion molecule-1 (VCAM-1) with an IC50 of 7 μg/mL and consequently has potential for the treatment of arteriosclerosis, asthma, and cancer.3 As is evident from examination of their structures, both pinnaic acid and halichlorine possess several interesting features, one of which they have in common is the azaspiro[4.5]decane ring system.

Figure 1.

Figure 1

Structures of pinnaic acid (1) and (+)-halichlorine (2).

Because of their intriguing structures and biological activities, these alkaloids have attracted considerable attention in the synthetic community. However, although a rather large number of groups have published their respective approaches toward the assembly of the azaspirobicyclic core,4 only three total syntheses of 15,6,7 and two total syntheses of 2 have been reported;7,8 there have been two formal syntheses of 1 and 2.9,10

Our approach to 1 and 2 was guided by a longstanding interest in developing new applications of olefin metathesis for the synthesis of complex natural products, particularly alkaloids.11,12 We thus envisioned a unified strategy for the preparation of both of these alkaloids that would feature chemoselective cross metathesis reactions involving the key intermediate 10 (Scheme 1).

Scheme 1.

Scheme 1

Retrosynthesis of Pinnaic Acid (1) and Halichlorine (2).

A novel route to the diene 5, a known intermediate that had been previously transformed into pinnaic acid (1) via 3,5 would entail a cross metathesis reaction between 10 and the dienoate 813 in the presence of Grubbs’ second generation metathesis catalyst (7).14 Similarly, a cross metathesis reaction between 10 and a dienoate such as 9, which bears a leaving group R, would lead to 6, a possible intermediate en route to halichlorine (2). The opportunity to extend the scope of olefin cross metathesis15 rendered this general approach to 1 and 2 particularly attractive. Olefin 10 would in turn be prepared by a Curtius rearrangement of a compound derived from 11, whose synthesis via an efficient three-component reaction was reported by Heathcock.16

The formal synthesis of pinnaic acid (1) is summarized in Scheme 2. Selective silylation of the diol 12 with TBDPSCl, Et3N and catalytic DMAP afforded 13 in 87% yield. Jones oxidation of 13 furnished carboxylic acid 14, which was subjected to a Curtius rearrangement with diphenyl phosphoryl azide (DPPA)17 and t-BuOH to afford 10 in 51% yield for the two steps.

Scheme 2.

Scheme 2

Formal Synthesis of Pinnaic Acid (1).

With the common intermediate 10 in hand, the stage was set for the pivotal cross metathesis reaction. Heating a mixture of 10 and dienoate 8 under reflux (CH2Cl2) for 3 h in the presence of Grubbs II catalyst (7) (10 mol %) provided an inseparable mixture of 5 and the dimer of 8.18,19 Pure 5 (E/Z = 10:1) could be obtained by a sequence of reactions involving removal of the N-Boc group, purification of the intermediate amine, and reinstallation of the N-Boc group (29% overall yield). Owing to the inefficiency of this process and practical considerations, we decided to telescope three reactions. In the event, the azaspirobicycle 15 was prepared in 34% overall yield via chemoselective cross metathesis of 8 and 10, followed by removal of the N-Boc group and cyclization of the intermediate amino dienoate via intramolecular 1,6-conjugate addition. Subsequent protection of 15 as its trifluoroacetamide derivative afforded 3.5a Spectral data of 3 were consistent with those reported by Kibayashi.9 Inasmuch as 3 had been previously converted into pinnaic acid (1) by Danishefsky,5b the preparation of 3 in 11 steps (5.8% overall yield) starting from commercially available methyl 1-cyclopentene-1-carboxylate completes a formal synthesis of 1.

The application of a different cross metathesis to the formal synthesis of halichlorine (2) was then explored. While we were able to access structures of the general type 6,20 cyclizations of amines obtained upon N-deprotection of such compounds via intramolecular 1,6-conjugate addition were problematic, perhaps owing to competing elimination pathways. Although such conversions are still being explored, an alternative route to 4 was developed.

We discovered that the cross metathesis reaction of 10 with crotonaldehyde proceeded in 89% yield with excellent diastereoselectivity (>20:1 E/Z ratio) (Scheme 3). When this cross metathesis reaction was performed using acrolein, the more common coupling partner for this transformation, lower yields (30–35%) were consistently obtained with the bulk of the mass balance being unreacted olefin 10. Thus, the use of crotonaldehyde in such constructions provides significant advantage.

Scheme 3.

Scheme 3

Formal Synthesis of Halichlorine (2).

Removal of the N-Boc group of 16 with TFA followed by neutralization at 0 °C with aqueous K2CO3 triggered an aza-Michael cyclization to furnish aldehyde 17 in 80% yield (dr = >20:1). The observed diastereoselectivity in this reaction was consistent with findings by Danishefsky in a similar system.21

Developing an efficient and new means of transforming 17 into 19 represented a significant challenge. Among several tactics that were explored, we considered that 18 might serve as a useful intermediate. Although the Baylis-Hillman reaction might seem well-suited to such a construction,22 neither it nor its many variants delivered 18 in acceptable yield. On the other hand, recruitment of Ramachandran’s vinylalumination methodolgy23 delivered 18 as an inconsequential mixture of diastereomers (dr = 2:1). Acetylation of this mixture under standard conditions led to a facile cyclization that provided the known tricycle 199 in 40% overall yield.24 Treatment of 19 with triethylamine trihydrofluoride (Et3N·3HF)25 removed the silyl ether moiety to furnish 4 in 91% yield. Spectral data of 4 were consistent with those reported by Kibayashi in his formal synthesis of halichlorine (2).9 Thus, the synthesis of 4 in 12 linear steps (5.1% overall yield) starting from commercially available methyl 1-cyclopentene-1-carboxylate constitutes a formal synthesis of 2.

In summary, concise formal syntheses of pinnaic acid (1) and halichlorine (2) have been accomplished by intercepting the known intermediates 3 and 4, respectively. The unified strategy for preparing 3 and 4 highlights the utility of olefin cross metathesis methodologies for the efficient construction of key olefinic bonds in the arena of natural product synthesis. Other applications of olefin metathesis to solving problems in total synthesis are under active investigation, and the results of these studies will be disclosed in due course.

Supplementary Material

1si20051029_12. Supporting Information Available.

Experimental procedures for 35, 10, 1319. 1H spectra for 35, 10, 1317, 19. This material is available free of charge via the Internet at http://pubs.acs.org.

Acknowledgments

We thank the National Institutes of Health (GM 25439), Pfizer, Inc., Merck Research Laboratories, and the Robert A. Welch Foundation for their generous support of this research. We are grateful to Prof. Dirk Trauner for providing copies of experimental procedures and spectral data of several intermediates and to Prof. Chihiro Kibayashi for providing us with copies of spectra of 4. We are also grateful to Dr. Richard Fisher (Materia, Inc.) for catalyst support and helpful discussions. An NIH Postdoctoral Fellowship to R.B.A. is gratefully acknowledged.

References

  • 1.Chou T, Kuramoto M, Otani Y, Yamada K, Shikano M, Yazawa K, Uemura D. Tetrahedron Lett. 1996;37:3871. [Google Scholar]
  • 2.Kuramoto M, Tong C, Yamada K, Chiba T, Hayashi Y, Uemura D. Tetrahedron Lett. 1996;37:3867. [Google Scholar]
  • 3.(a) Postigo AA, Teixido J, Sanchezmadrid F. Res Immunol. 1993;144:723. doi: 10.1016/s0923-2494(93)80057-6. [DOI] [PubMed] [Google Scholar]; (b) Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Nature. 1995;376:517. doi: 10.1038/376517a0. [DOI] [PubMed] [Google Scholar]; (c) Carlos TM, Harlan JM. Blood. 1994;84:2068. [PubMed] [Google Scholar]
  • 4.(a) Arimoto H, Asano S, Uemura D. Tetrahedron Lett. 1999;40:3583. [Google Scholar]; (b) Trauner D, Danishefsky SJ. Tetrahedron Lett. 1999;40:6513. [Google Scholar]; (c) Clive DLJ, Yeh VSC. Tetrahedron Lett. 1999;40:8503. [Google Scholar]; (d) Koviach JL, Forsyth CJ. Tetrahedron Lett. 1999;40:8529. [Google Scholar]; (e) Lee S, Zhao Z. Org Lett. 1999;1:681. [Google Scholar]; (f) Shindo M, Fukuda Y, Shishido K. Tetrahedron Lett. 2000;41:929. [Google Scholar]; (g) Wright DL, Schulte JP, II, Page MA. Org Lett. 2000;2:1847. doi: 10.1021/ol005903b. [DOI] [PubMed] [Google Scholar]; (h) White JD, Blakemore PR, Korf EA, Yokochi AFT. Org Lett. 2001;3:413. doi: 10.1021/ol000361j. [DOI] [PubMed] [Google Scholar]; (i) Takasu H, Ohsat H, Ihara M. Org Lett. 2003;5:3017. doi: 10.1021/ol034942v. [DOI] [PubMed] [Google Scholar]; (j) Matsumura Y, Aoyagi S, Kibayashi C. Org Lett. 2003;5:3249. doi: 10.1021/ol030073y. [DOI] [PubMed] [Google Scholar]; (k) Yu ML, Clive DLJ, Yeh VSC, Kang SZ, Wang H. Tetrahedron Lett. 2004;45:2879. [Google Scholar]; (l) Hayakawa I, Arimoto H, Uemura D. Chem Commun. 2004:1222. [Google Scholar]; (m) Nieczypor P, Mol JC, Bespalova NB. Eur J Org Chem. 2004;4:812. [Google Scholar]; (n) Yu ML, Clive DLJ, Yeh VSC, Kang SZ, Wang H. Tetrahedron Lett. 2004;45:2879. [Google Scholar]; (o) Arini LG, Szeto P, Hughes DL, Stockman RA. Tetrahedron Lett. 2004;45:8371. [Google Scholar]; (p) Feldman KS, Perkins AL, Masters KM. J Org Chem. 2004;69:7928. doi: 10.1021/jo0487911. [DOI] [PubMed] [Google Scholar]; (q) Huxford T, Simpkins NS. Synlett. 2004;13:2295. [Google Scholar]; (r) Clive DLJ, Yu ML, Li ZY. Chem Commun. 2005:906. doi: 10.1039/b413481h. [DOI] [PubMed] [Google Scholar]; (s) de Souza A, Pilli R. Org Lett. 2005;7:1617. doi: 10.1021/ol050306g. [DOI] [PubMed] [Google Scholar]; (t) Clive DLJ, Wang J, Yu M. Tetrahedron Lett. 2005;46:2853. [Google Scholar]
  • 5.(a) Carson MW, Kim G, Hentemann MF, Trauner D, Danishefsky SJ. Angew Chem Int Ed. 2001;40:4450. doi: 10.1002/1521-3773(20011203)40:23<4450::aid-anie4450>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]; (b) Carson MW, Kim G, Danishefsky SJ. Angew Chem Int Ed. 2001;40:4453. doi: 10.1002/1521-3773(20011203)40:23<4453::aid-anie4453>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  • 6.Hayakawa I, Arimoto H, Uemura D. Heterocycles. 2003;59:441. [Google Scholar]
  • 7.Christie HS, Heathcock CH. Proc Natl Acad Sci USA. 2004;101:12079. doi: 10.1073/pnas.0403887101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Trauner D, Schwartz JB, Danishefsky SJ. Angew Chem Int Ed. 1999;38:3542. doi: 10.1002/(sici)1521-3773(19991203)38:23<3542::aid-anie3542>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  • 9.Matsumura Y, Aoyagi S, Kibayashi C. Org Lett. 2004;6:965. doi: 10.1021/ol0301431. [DOI] [PubMed] [Google Scholar]
  • 10.Zhang HL, Zhao G, Ding Y, Wu B. J Org Chem. 2005;70:4954. doi: 10.1021/jo047882v. [DOI] [PubMed] [Google Scholar]
  • 11.For a review, see: Deiters A, Martin SF. Chem Rev. 2004;104:2199. doi: 10.1021/cr0200872. and references cited therein.
  • 12.For some selected examples, see: Martin SF, Humphrey JM, Liao Y, Ali A, Rein T, Wong YL, Chen HJ, Courtney AK. J Am Chem Soc. 2002;124:8584. doi: 10.1021/ja0202964.Deiters A, Martin SF. Org Lett. 2002;4:3243. doi: 10.1021/ol026470a.Martin SF, Neipp CE. J Org Chem. 2003;68:8867. doi: 10.1021/jo0349936.Washburn DG, Heidebrecht RW, Jr, Martin SF. Org Lett. 2003;5:3523. doi: 10.1021/ol0354066.Brenneman JB, Machauer R, Martin SF. Tetrahedron. 2004;60:7301.
  • 13.Piers E, Jung GL, Ruediger EH. Can J Chem. 1987;65:670. [Google Scholar]
  • 14.Scholl M, Ding S, Lee CW, Grubbs RH. Org Lett. 1999;1:953. doi: 10.1021/ol990909q. [DOI] [PubMed] [Google Scholar]
  • 15.Chatterjee AK, Choi TL, Sanders DP, Grubbs RH. J Am Chem Soc. 2003;125:11360. doi: 10.1021/ja0214882. [DOI] [PubMed] [Google Scholar]
  • 16.Wallace GA, Heathcock CH. J Org Chem. 2001;66 doi: 10.1021/jo001145r. See reference 4s for a related tandem sequence to prepare an analog of 11.
  • 17.Ninomiya K, Shioiri T, Yamada S. Tetrahedron. 1974;30:2151. [Google Scholar]
  • 18.For a similar synthesis of α-bromo-α,β,δ,γ-dienoates, see: Funk TW, Efskind J, Grubbs RH. Org Lett. 2005;7:187. doi: 10.1021/ol047929z.
  • 19.Initial experiments using ethyl 2-methyl-2,4-pentadienoate as the diene component in the cross metathesis also provided 5, albeit in slightly lower yield. Small amounts of the homodimer of 10 were sometimes observed but not under the conditions reported herein. No other products derived from 10 could be isolated and characterized.
  • 20.The cross metathesis reaction of 10 and 9 (R = OAc) (10 mol % 7, CH2Cl2, reflux, 3 h) afforded 6 (R = OAc) in 59% yield (>10:1 E/Z ratio).
  • 21.Trauner D, Churchill DG, Danishefsky SJ. Helv Chim Acta. 2000;83:2344. [Google Scholar]
  • 22.Basavaiah D, Rao AJ, Satyanarayana T. Chem Rev. 2003;103:811. doi: 10.1021/cr010043d. [DOI] [PubMed] [Google Scholar]
  • 23.Ramachandran PV, Rudd MT, Burghardt TE, Reddy MVR. J Org Chem. 2003;68:9310. doi: 10.1021/jo034954u. [DOI] [PubMed] [Google Scholar]
  • 24.For a related cyclization, see reference 4r.
  • 25.For a review, see: McClinton MA. Aldrichim Acta. 1995;28:31.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1si20051029_12. Supporting Information Available.

Experimental procedures for 35, 10, 1319. 1H spectra for 35, 10, 1317, 19. This material is available free of charge via the Internet at http://pubs.acs.org.

RESOURCES